First, the honest label: NAD+ is not a peptide. It's a coenzyme built on nucleotides, not amino acids — we cover it in the peptides section only because it's the injectable "longevity clinic" compound people ask about in the same breath. Our injectable NAD+ card gives the short version; this guide goes deeper on why the underlying science is genuinely interesting, and why the case for paying for the drip is much weaker than the marketing suggests.
- NAD+ is a coenzyme every cell uses for energy and DNA repair, and its levels fall with age — that decline is the real hook.
- Human evidence for IV NAD+ specifically is very limited; the best data is pharmacokinetic (how it's processed), not proof of benefit.
- Oral precursors (NMN, NR) also raise NAD+, far more cheaply and without a needle — the added value of the IV route isn't established.
- Drips are slow, pricey, sourced from compounding pharmacies, and not FDA-approved for any of these uses.
The biology is real
NAD+ (nicotinamide adenine dinucleotide) is one of the most important molecules in your cells. It shuttles electrons in the mitochondria to help turn food into energy, and it's a required cofactor for the repair-and-signaling enzymes — sirtuins and PARPs — that respond to cellular stress and DNA damage. Tissue NAD+ levels decline measurably with age, driven both by making less and consuming more, which is the theoretical foundation for "topping it back up" as an anti-aging strategy.[2] That much is solid science.
Why people get the drip
Longevity and IV clinics market NAD+ infusions for energy, mental clarity, focus, "anti-aging," and addiction recovery. The pitch versus a pill is that injecting or infusing NAD+ skips digestion and first-pass metabolism. That sounds compelling — but it's also invasive, slow, and expensive, and it glosses over an inconvenient fact: oral precursors like NMN and NR raise NAD+ too, for a fraction of the cost and hassle. If the goal is simply higher NAD+, the needle isn't clearly buying you anything extra. (See our NMN guide for the oral side of this story.)
What the research actually shows
Here's where enthusiasm meets reality. Human trial evidence for IV NAD+ specifically ranges from very limited to essentially absent, and most clinic claims are mechanism plus testimonial rather than controlled data.
The strongest human study is pharmacokinetic, not outcome-based: researchers tracked what happens to NAD+ and its metabolites in blood and urine during a 6-hour IV infusion, showing NAD+ is actively broken down and processed rather than simply pooling in the bloodstream.[1] That's a genuine scientific first — a look at how the molecule moves through the body — but it says nothing about whether you feel better, think more clearly, or age more slowly. For the popular "NAD therapy" addiction protocols, the evidence is anecdotal or from small, uncontrolled pilots, and even sympathetic authors call for real randomized trials.
One practical detail explains a lot: infusions are run deliberately slowly — often over one to several hours — because pushing NAD+ in quickly causes nausea, cramping, flushing, and chest pressure. That's not a sign of potency; it's a tolerability workaround.
The honest read: intriguing mechanism, thin outcome evidence. NAD+ decline is real, but "IV NAD+ makes you younger, sharper, or drug-free" is not something controlled human trials have shown.
Selected Research
- Grant et al., Frontiers in Aging Neuroscience, 2019 — first human study of the plasma/urine NAD+ metabolome during a 6-hour IV NAD+ infusion, showing NAD+ is actively metabolized (pharmacokinetics, not an outcome trial). PMC
- Covarrubias et al., Nature Reviews Molecular Cell Biology, 2021 — NAD+ levels decline with age across tissues, the rationale behind NAD+-boosting therapies. Nature
IV NAD+ is not FDA-approved for anti-aging, energy, cognitive, or addiction uses, and human outcome evidence is minimal. Cited for education only — not medical advice or a guarantee of results.